|
|
See Category: Neoplasms
See Header: Malignant neoplasm of breast of unspecified site, female
ICD-10 (CM) Code and Descriptor
|
C50.912 |
Malignant neoplasm of unspecified site of left female breast
|
C50912 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 53.52%
|
24.30%
|
9.38%
|
4.62%
|
2.62%
|
1.70%
|
1.11%
|
0.75%
|
0.56%
|
0.37%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C50.912*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
82,703
|
83,110
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
59,376
|
59,391
|
|
80053
|
COMPREHEN METABOLIC PANEL |
56,990
|
56,994
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
47,089
|
47,224
|
|
86300
|
IMMUNOASSAY TUMOR CA 15-3 |
21,459
|
23,273
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
14,628
|
14,711
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
11,829
|
23,321
|
|
J3010
|
FENTANYL CITRATE INJECTION |
10,719
|
18,448
|
|
J2405
|
ONDANSETRON HCL INJECTION |
10,704
|
60,308
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
10,026
|
85,498
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
9,122
|
300,853
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
8,722
|
35,286
|
|
96413
|
CHEMO IV INFUSION 1 HR |
8,422
|
8,422
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
8,190
|
8,682
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
7,519
|
11,177
|
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
7,430
|
7,430
|
|
J1642
|
INJ HEPARIN SODIUM PER 10 U |
7,366
|
347,132
|
|
77387
|
GUIDANCE FOR RADJ TX DLVR |
7,051
|
7,095
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
6,967
|
11,430
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
6,886
|
19,111
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C50.912 related to the following DRG Codes:
582-583
597-599
|
